Open Flexible Dose Optimisation Trial Assessing Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy Who Are Treatment Naive or Have Failed One Anti-Epileptic Drug Treatment in Monotherapy

Trial Profile

Open Flexible Dose Optimisation Trial Assessing Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy Who Are Treatment Naive or Have Failed One Anti-Epileptic Drug Treatment in Monotherapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Apr 2013

At a glance

  • Drugs Topiramate (Primary)
  • Indications Partial epilepsies; Tonic-clonic epilepsy
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Johnson & Johnson
  • Most Recent Events

    • 20 Nov 2012 Primary endpoints amended as reported by ClinicalTrials.gov.
    • 24 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top